Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Debt (2023 - 2026)

Cannabis Bioscience International Holdings' Total Debt history spans 4 years, with the latest figure at $264092.0 for Q1 2026.

  • On a quarterly basis, Total Debt fell 18.17% to $264092.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $264092.0, a 18.17% decrease, with the full-year FY2025 number at $264092.0, up 5.91% from a year prior.
  • Total Debt hit $264092.0 in Q1 2026 for Cannabis Bioscience International Holdings, roughly flat from $264092.0 in the prior quarter.
  • Over the last five years, Total Debt for CBIH hit a ceiling of $322729.0 in Q1 2025 and a floor of $249361.0 in Q2 2024.
  • Historically, Total Debt has averaged $265157.9 across 4 years, with a median of $264092.0 in 2023.
  • Biggest five-year swings in Total Debt: increased 25.79% in 2025 and later decreased 18.17% in 2026.
  • Tracing CBIH's Total Debt over 4 years: stood at $261579.0 in 2023, then increased by 0.96% to $264092.0 in 2024, then changed by 0.0% to $264092.0 in 2025, then changed by 0.0% to $264092.0 in 2026.
  • Business Quant data shows Total Debt for CBIH at $264092.0 in Q1 2026, $264092.0 in Q4 2025, and $249500.0 in Q3 2025.